This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stock Under $10 that he thinks could potentially double or triple in the next 6 to 12-months. See what he's trading today with a 14-day FREE pass.

Cramer: How Perfect Stocks Morph Into Lemons

Then there's AMN Healthcare Services (AHS), a $600 million company that's a one-stop shop for all of the staffing needs for hospitals -- a terrific story that should get better with age as we go into Obamacare and more and more people become elderly because of the nation's changing demographics. This is a terrific little company that's the largest in its industry with a very bright CEO, Susan Salka, and an even brighter future.

Many businesses will be challenged by Obamacare, but hospitals are not one of them -- and when they need doctors or nurses and don't want to put them on full staff, they will call AMN Healthcare. I found myself wondering why this stock's market capitalization is only at $600 million, as this company's total addressable market is huge and it's recognized as best in class in the industry.

But then I thought about it and recognized that, with a tougher market, no big mutual fund is going to want to get trapped in a junior growth stock with no place to go if things go wrong. Stocks like AMN are magic-carpet rides until they become roach motels when the tape morphs from glorious to toxic.

Salesforce.com, a cloud play; Radian, a housing play; and AMN, a healthcare play: These stocks were all perfect just a few weeks ago. Now they're facing challenges as the buyers reassess their commitments and sellers ring the register.

At the time of publication, Action Alerts PLUS, which Cramer co-manages as a charitable trust, had no positions in the stocks mentioned.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
DOW 17,122.01 +15.31 0.09%
S&P 500 2,000.12 +0.10 0.00%
NASDAQ 4,569.6210 -1.0160 -0.02%

Our Tweets

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs